NPAT collapsed 90.4% on one-off charges, dividend halved to 2 cents

Management's underlying NPAT was NZ$10.7m, with the gap to reported attributed to one-off regulatory assurance and other items. The PBT margin of 3.4% is an unprecedented low against a four-period historical range of 37.2%-49.6%, and ROE of 0.3% is also unprecedented low against the 6.1%-10.8% historical range.

The interim dividend was cut from 4.0 to 2.0 cents, but the implied NPAT payout ratio still rose to 500% versus a historical 67%-76% range. Total assets grew 10.4% to NZ$8.8b, indicating the lending franchise itself continued to expand even as profitability evaporated.

Underlying NPAT of NZ$10.7m is roughly 72% below the prior comparable's NZ$37.6m. So while one-off regulatory assurance charges explain most of the headline gap, this is not purely a presentation issue — the core run-rate compressed materially. NOI grew 8.4%, which means cost growth, credit charges or both expanded faster than the income base.

The dividend signal is sharper than the cut itself. Halving the dividend to 2.0 cps is consistent with the 500% NPAT payout ratio versus a historical 67%-76% range — the distribution is now being funded from retained earnings or capital, not from the period's profit. This matters because it tells investors the board sees the earnings reset as durable enough to warrant rebasing capital returns.

The effective tax rate jumped to 32.4% (unprecedented high) from 28.5%. When PBT is only NZ$5.3m, non-deductible items disproportionately inflate the rate, so this is partly a denominator effect rather than a sustained tax change — but it amplified the NPAT hit relative to PBT and should normalise as PBT recovers.

Historical shape data shows HY24 was 48.6% of FY24 revenue and 50.4% of FY24 NPAT, so Heartland has not historically been heavily second-half weighted. Annualising HY25 revenue gives roughly NZ$310.6m, broadly in line with FY24's NZ$290.7m, so the top-line is tracking ahead.

The bottom-line picture is far less supported. Even doubling underlying HY25 NPAT of NZ$10.7m points to a full-year run-rate well below FY24's NZ$74.5m, and the release flags continued macro volatility. Without management quantifying which one-offs will not recur in 2H25, the release does not support a clean profit recovery path for the second half.

The reported NZ$3.6m NPAT is materially distorted by one-off charges, while the underlying NZ$10.7m is itself a sharp step-down from prior periods on a like-for-like basis. The PBT margin of 3.4%, NPAT margin of 2.3% and ROE of 0.3% are all unprecedented lows in the historical baseline supplied.

Operating cash flow swung from negative NZ$8.8m to positive NZ$236.6m, and pre-lease free cash flow of NZ$234.8m is within the historical NZ$-150.9m to NZ$297.2m range. For a balance-sheet lender, however, period operating cash flow is dominated by movements in receivables, deposits and wholesale funding rather than operating earnings, so this swing should not be read as a sign of underlying earnings quality. Capex fell 89.1% to NZ$1.8m (1.2% of revenue), which lowers near-term cash demands but does not address the earnings issue.

The gross borrowings line shows NZ$1.4b versus NZ$6.8b, but the source labels indicate the prior period figure is "Total deposits and other borrowings" while the current is "Other borrowings" only, so the apparent leverage decline is not a clean comparison.

This briefing cannot assess the credit quality of Heartland's lending book or the recoverability of the assurance-related charges without underlying provisioning and segment-level disclosure.